According to the FDA briefing document, severe systemic reactions were 4× MORE COMMON with the mRNA flu shot than with the traditional flu shot.

*

In a dark day for MAHA, the FDA has approved Moderna’s mFLUSIVA for adults 50 …

The post FDA Approves Moderna’s First-ever mRNA Flu Shot Despite 75.3% Adverse Reaction Rate appeared first on Global Research.